You are browsing the archive for Draper Fisher Jurvetson - peHUB.
Ben Franklin Technology Partners Southeastern PA, a Philadelphia-based early-stage backer, invested $1.54 million in 11 deals during March, ranking it as the most active investor in the month. Draper Fisher Jurvetson was the most active institutional venture firm in the month, having backed seven companies with nearly $9 million, according to Thomson Reuters data.
Jurvetson, a managing director at Draper Fisher Jurvetson and an investor in Elon Musk’s SpaceX, sees big opportunities opening up from low-cost space travel and reusable rockets.
Retailigence, a Redwood City, Calif.-based company whose back-end database helps track whether items are stocked in the stores of its retail customers, has raised $6.3 million in new funding from its existing investors Draper Fisher Jurvetson and Motorola Solutions, along with new investors Telenav and OPT, one of Japan’s largest digital ad agencies. Retailigence had previously raised $4.2 million.
Virool, a year-old San Francisco-based video advertising startup, has closed on $6.62 million in funding from a long list of investors in what the company claims is the biggest seed round raised so far by a graduate of the the Y Combinator incubator program. (Virool came out of the program last summer.) The company’s institutional investors include Draper Fisher Juvetson and Menlo Ventures; individuals who contributed to the funding include Paul Buchheit, Dave McClure, and Yuri Milner.
Venture investors put $6.46 billion to work during the year, down from $9.61 billion in 2011, the Cleantech Group reports. The number of deals came in at 704, which was down 15% from a year earlier…
Nantero has closed a Series D round of financing for over $10 million. The oversubscribed round was led by two new strategic corporate investors and also includes existing investors, including Charles River Ventures, Draper Fisher Jurvetson, Globespan Capital Partners, Stata Venture Partners and Harris & Harris Group.
NanoString Technologies, a provider of life science tools for translational research and developer of molecular diagnostic products, has completed a $15.3 million Series E Preferred Stock issuance. New investors in the transaction included Morgan Stanley Expansion Capital and AllianceBernstein Alternative Investment Management Group. All previous venture investors participated including Clarus Ventures, Draper Fisher Jurvetson, OVP Venture Partners, GE healthymagination Fund, BioMed Ventures, and Henri Termeer.